CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

Clinical trial NCT05942872 · COMPLETED

Trial details

NCT number: NCT05942872
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Study type: OBSERVATIONAL

Paraneoplastic Syndromes

Start date: 2021-04-01
Primary completion: 2021-07-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.